New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Updated on: September 28,2024

New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Updated on:September 28,2024

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on: January 23,2024

Study finds increased MDS/leukemia risks for survivors of common lymphoid neoplasms

by Elana GotkineSurvivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more

Updated on:January 23,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on: February 18,2024

FDA Approves Two Cell-Based SCD Gene Therapies

February 2024The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patient

Updated on:February 18,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Updated on: June 15,2024

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia

by Case Western Reserve University'If we started to treat mice with the antibody early during disease development, leukemia was almost eradicated by this treatment method; however, if treatme

Updated on:June 15,2024

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease

Updated on: January 02,2024

Population scientist identifies rapid rise in cervical cancer in millennial women

byMedical University of South CarolinaHigh grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease

Updated on:January 02,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on: March 30,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on:March 30,2024

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on: March 06,2024

New insight into aggressive breast cancers

by Cardiff UniversityCredit: CC0 Public DomainScientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improv

Updated on:March 06,2024

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Updated on: January 15,2024

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Updated on:January 15,2024

Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

byAmerican Society of HematologyCredit: Unsplash/CC0 Public DomainNumerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new me

Updated on: January 15,2024

Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

byAmerican Society of HematologyCredit: Unsplash/CC0 Public DomainNumerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new me

Updated on:January 15,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on: January 15,2024

Shape-shifting fat cells fuel breast cancer growth

Updated on:January 15,2024